The majority of the reported events occurred in patients who experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting or diarrhea
Usually, these guidelines are written by a group of independent scientists and doctors
Giorgi Pkhakadze, MD, MPH, PhD GMJ News Desk A substantial proportion of patients who discontinue GLP-1 receptor agonist medications for type 2 diabetes eventually resume treatment, according to recent analysis of patient treatment patterns
The team wanted to determine whether these variants also disrupt GLP-1, a hormone produced in the gut that helps control blood sugar after meals by stimulating insulin release, slowing stomach emptying, and reducing appetite
However, the length of your treatment will depend on your metabolism and your body type